MS
Octave Bioscience to Conduct Real-World Multiple Sclerosis Study Using Management Platform
The 150-patient, Biogen-sponsored study will use Octave's Precision Care Solution platform to better understand how MS progresses.
Siemens Healthineers, Novartis Ink Deal to Develop Assays With Initial Focus on MS Therapeutics
An initial program aims at the development of a serum neurofilament light chain immunoassay to support Novartis' MS and other neuroscience programs.